SLC25A51 is the primary mitochondrial NAD+ transporter in humans and controls many local reactions by mediating the influx of oxidized NAD+. Intriguingly, SLC25A51 lacks several key features compared with other members in the mitochondrial carrier family, thus its molecular mechanism has been unclear. A deeper understanding would shed light on the control of cellular respiration, the citric acid cycle, and free NAD+ concentrations in mammalian mitochondria. This review discusses recent insights into the transport mechanism of SLC25A51, and in the process highlights a multitiered regulation that governs NAD+ transport. The aspects regulating SLC25A51 import activity can be categorized as contributions from (1) structural characteristics of the transporter itself, (2) its microenvironment, and (3) distinctive properties of the transported ligand. These unique mechanisms further evoke compelling new ideas for modulating the activity of this transporter, as well as new mechanistic models for the mitochondrial carrier family.
-
Cover Image
Cover Image
The versatile programmability of CRISPR system has been utilized in various applications for RNA sensing. In this issue Liu and colleagues review how scientists engineer the guide RNAs (gRNAs) in CRISPR systems and create diverse strategies for designing RNA sensors. These approaches can not only detect target RNA molecules in vitro but also enable the regulation of gene expression in response to specific RNA molecules in vivo. Image provided by Yang Liu.
Layered mechanisms regulating the human mitochondrial NAD+ transporter SLC25A51
Shivansh Goyal, Xiaolu A. Cambronne; Layered mechanisms regulating the human mitochondrial NAD+ transporter SLC25A51. Biochem Soc Trans 20 December 2023; 51 (6): 1989–2004. doi: https://doi.org/10.1042/BST20220318
Download citation file:
Sign in
Sign in to your personal account
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Get Email Alerts
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |